Sign in
Taking people in United StatesNo phase

Bottarga fish roe in adults with prediabetes, diabetes, or high cholesterol

Tests daily bottarga fish roe in adults with metabolic health problems.

Key facts

Who runs it
Cambridge Health Alliance
Where
Sommerville, United StatesSee the site
Trial code
Registry title
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
Status
Recruiting
People taking part
20 people, planned
Started
17 Oct 2025
Expected to end
1 Mar 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Bottarga
  • Comparator
Record updated
16 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18-60 who live in Massachusetts and have at least one metabolic abnormality or diabetes. They will eat Greek bottarga (grey mullet fish roe) or a dairy product each day.

Age
18 to 60 years
Sex
Men and women can join.
Disease stage
At least one metabolic abnormality (low HDL cholesterol, high LDL cholesterol, high triglycerides, obesity, or HbA1c ≥ 5.7% (39 mmol/mol)) or a diagnosis of diabetes.
Earlier treatment
People cannot be using diabetes medicines (except metformin), cholesterol medicines (except statins), immunosuppressive medicines, hormone therapy (except oral contraceptives), or supplements containing n-3 fatty acids.
Biomarker or test result
HbA1c of 5.7% (39 mmol/mol) or higher, or abnormal HDL, LDL or triglyceride levels, count as a metabolic abnormality.

Main reasons for not taking part

  • Allergy to fish, seafood or fish-derived products
  • Pregnancy
  • Liver or kidney insufficiency, now or in the past
  • Immunodeficiency conditions
  • History of non-skin cancer

The registry criteria, word for word

Show all 15 criteriaShow less

Who cannot take part

  • Current use of illicit drugs (other than marijuana)
  • Use of hormone therapy (except oral contraceptives)
  • Use of any medications for diabetes (except metformin), dyslipidemia (except statins), or immunosuppression
  • Known allergies to fish, seafood, or any fish-derived products, including bottarga
  • Clinical evidence or history of hepatic or renal insufficiency
  • Immunodeficiency conditions
  • History of non-skin cancer
  • Current use of any supplements containing n-3 fatty acids
  • Pregnancy
  • Participation in other clinical research studies

Other criteria

  • Adults aged 18-60 years
  • Residents of Massachusetts
  • Presence of at least one metabolic abnormality (low HDL cholesterol, elevated LDL cholesterol, elevated triglycerides, obesity, or HbA1c ≥ 5.7%) or a diagnosis of diabetes
  • Not pregnant
  • Willing to consume a nutritional supplement and comply with study procedures

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Where in United States

  • Cambridge Health AllianceSommerville, United StatesContact: Patricia LenehanTaking people

About the trial

What the trial wants to find out

This pilot study aims to explore the potential benefits of consuming Greek bottarga (grey mullet fish roe) in individuals with at least one metabolic abnormality (low HDL cholesterol, high LDL cholesterol, high triglycerides, obesity, or HbA1c ≥ 5.7%) or a diagnosis of diabetes.

Read full original descriptionShow less

Before initiating the crossover randomized controlled trial (RCT), the investigators will conduct a preliminary dose-testing study in five adults with at least one metabolic abnormality. Participants will undergo clinical assessments before and after the dietary intervention to evaluate changes in metabolic health markers. Following this phase, the investigators will proceed with a randomized, controlled crossover trial involving 20 eligible adult participants. This main study phase will compare the metabolic effects of daily bottarga supplementation with those of a calorically matched dairy product over an 8-week intervention period, with a 2-week washout period between interventions.

The investigators anticipate that bottarga supplementation will improve lipid profiles, inflammation markers, and insulin resistance, thereby supporting the potential use of sustainable blue foods as part of a healthy diet.

The 2 groups in the trial

  • Bottarga supplementation (intervention group)Treatment being tested

    Ten participants with at least one metabolic abnormality (low HDL cholesterol, high LDL cholesterol, high triglycerides, obesity, or HbA1c ≥ 5.7%) or a diagnosis of diabetes will be randomly allocated to 8 weeks of daily bottarga supplementation (20 grams/day; participants weighing \>100 kg \[220 lbs\] will consume 40 g/day) as an initial treatment. Baseline assessment measures will be repeated, followed by a 2-week wash-out period. Then, assessment measures will be repeated followed by 8 weeks of daily cream cheese supplementation (28 grams/day; participants weighing \>100 kg \[220 lbs\] will consume 56 g/day), followed by final assessment measures.

    Treatment: Bottarga

  • Cream cheese supplementation (control)Sham treatment, for comparison

    Ten participants with at least one metabolic abnormality (low HDL cholesterol, high LDL cholesterol, high triglycerides, obesity, or HbA1c ≥ 5.7%) or a diagnosis of diabetes will be randomly allocated to 8 weeks of daily cream cheese supplementation (28 g/day) as the initial intervention. Baseline assessment measures will be repeated, followed by a 2-week wash-out period. Then, assessment measures will be repeated, followed by 8 weeks of daily Bottarga supplementation (20 g/day;participants weighing \>100 kg \[220 lbs\] will consume 40 g/day), followed by final assessment measures.

    Treatment: Comparator

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
Plain-language title
Bottarga fish roe in adults with prediabetes, diabetes, or high cholesterolGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06988462, who can take part
Record updated
16 July 2026